See the rest here:
Zosano Pharma Receives Complete Response Letter from FDA for Qtrypta™
CORRECTING AND REPLACING: Eyenovia to Report Third Quarter 2021 Results on Wednesday, November 10
Orchestra BioMed™ Announces Presentations at TCT 2021 of Positive Long-Term Clinical Results from the MODERATO II Study Showing the Significant…
Shockwave Medical Unveils First One-Year Results of Coronary Intravascular Lithotripsy
Nicox’s Partner Ocumension Therapeutics Initiates ZERVIATE Phase 3 Clinical Trial in China
Here is the original post:
Nicox’s Partner Ocumension Therapeutics Initiates ZERVIATE Phase 3 Clinical Trial in China
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Continue reading here:
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Havn Life Sciences announces increase in Bought Deal Financing to $10 Million
See the original post here:
Havn Life Sciences announces increase in Bought Deal Financing to $10 Million
Ocuphire to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event in Early January 2021
Mesoblast Enters Global Collaboration for Development, Manufacture and Commercialization of Remestemcel-L
Affimed Announces Publication of Final Study Results of its Innate Cell Engager Candidate AFM13 in Combination with MSD’s anti-PD-1 therapy…
Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2020
Enosi Life Sciences Files Patent for TNF-Inhibiting Molecules EN1001, EN2001 and EN3001
Galera Therapeutics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
Go here to see the original:
Galera Therapeutics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
Harpoon Therapeutics Presents Encouraging Preclinical Data for HPN601 EpCAM ProTriTAC™ Program at 35th SITC Annual Meeting
European Commission approves Supemtek® (quadrivalent recombinant influenza vaccine) for the prevention of influenza in adults aged 18 years and older
Yield10 Bioscience to Announce Third Quarter 2020 Financial Results and Host a Conference Call on Thursday, November 12, 2020
T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech & Diagnostics Forum
Read more from the original source:
T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech & Diagnostics Forum